Aileron Therapeutics Inc (ALRN.OQ)
ALRN.OQ on NASDAQ Stock Exchange Global Market
3.33USD
18 Sep 2018
3.33USD
18 Sep 2018
Change (% chg)
-- (--)
-- (--)
Prev Close
$3.33
$3.33
Open
--
--
Day's High
--
--
Day's Low
--
--
Volume
--
--
Avg. Vol
23,802
23,802
52-wk High
$15.34
$15.34
52-wk Low
$1.98
$1.98
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- ownership
- filings
- deals
- private equity
- third-party document and information retrieval
- estimates
- fundamentals
- economics
- events
- news
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
| Name | Age | Since | Current Position |
|---|---|---|---|
Jeffrey Bailey |
55 | 2018 | Chairman of the Board |
Manuel Aivado |
48 | 2018 | President, Chief Executive Officer, Director |
Evan Lippman |
2015 | Chief Financial Officer and Business Officer, Senior Vice President | |
D. Allen Annis |
2007 | Vice President - Biophysical and Analytical Technologies | |
Seth Harrison |
56 | 2016 | Director |